Navigation Links
Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections

FREDERICK, Md., April 30 /PRNewswire/ -- Royer Animal Health, LLC, a wholly owned subsidiary of Royer Biomedical, Inc., has executed an exclusive distribution agreement with MWI Veterinary, Supply, Inc. (Nasdaq: MWIV) to market its lead animal health products: MATRIX III CISPLATIN BEADS and R-GEL ANTIBIOTIC WOUND DRESSING. These proprietary, timed-release products provide veterinary professionals with localized treatment options for cancer, infections, and general wound management.

By providing locally controlled delivery and increased drug concentration, Royer Animal Health therapies have proven to be highly effective, with no systemic side effects. These innovative products have only recently become available, they are currently being used in over 600 veterinary clinics and by 40 veterinary schools / teaching hospitals worldwide.

MATRIX III CISPLATIN BEADS have been clinically proven highly effective in the treatment of certain cancers with tumor rates of less than 10% reported. These fully-resorbable, [3 mm] Cisplatin Bead implants are indicated for use in the local control of equine sarcoids; clinical studies have also shown the effective use of Matrix III Cisplatin Beads in other tumor types including: melanoma, squamous cell, carcinoma and osteosarcoma. The product is safe, easy to use and manufactured under FDA -compliant conditions and represent a major breakthrough in cost-effective veterinary chemotherapy."

R-GEL ANTIBIOTIC WOUND DRESSING, is a timed-release antibiotic gel that solidifies in situ. It provides a sustained therapeutic dose of amikacin and clindamycin at the site of administration for a period of 7-9 days. The R-GEL matrix is biodegradable and fully resorbed in about 4 weeks. R-GEL has proven to be highly effective in the treatment of a wide range of small and large animal indications including: contaminated wounds, dental abscesses, deep lacerations, bite wounds, necrotic tissue, infected tendon sheaths, septic joints, post-operative orthopedic infections and hoof abscesses.

Supplied in a dual-syringe Kit for easy administration, R-GEL is available in both a 2ml and a 4 ml dose.

Dr. Gar Royer, President and CEO of Royer Animal Health, commented: "We are very pleased to be entering into this relationship with MWI, and believe that many new practitioners, as well as their patients and clients will benefit from the positive outcomes that will result by using our innovative products."

Royer Animal Health, LLC has developed novel superior products utilizing proprietary drug delivery technologies. Our mission is to provide veterinary professional with localized drug delivery products providing increased drug concentration to the targeted site versus systemic delivery, and consequently enhanced efficacy, without systemic side effects. Both Matrix III and R-Gel drug delivery matrices, are bio-resorbable, and have the ability to provide an effective, controlled release of drugs over a broad range of time spans. For more information about Royer Animal Health, please visit our website at

MWI is a distributor of animal health products to veterinarians across the United States. MWI sells pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, veterinary pet food and nutritional products. They market these products to veterinarians in both the companion animal and production animal markets. For more information about MWI, please visit our website at

For more information contact: Steve Kirschner at 301.696.2177

SOURCE Royer Animal Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nasal Anthrax Vaccine Proves Effective in Animal Study
2. Molecular probe paints cancer cells in living animals, Stanford researchers find
3. USC researcher identifies stem cells in tendons that regenerate tissue in animal model
4. UCSF animal care facility receives top accreditation
5. Why are some groups of animals so diverse?
6. Penn Veterinary Medicine report new strategy to create genetically modified animals
7. ABC TV San Francisco Features Canine Cancer Research Story: Saving Our Dogs, Helping Humans Beat Cancer - Work at Morris Animal Foundation, UC-Davis
8. Scientists get first look at nanotubes inside living animals
9. Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies
10. Fort Dodge Animal Health and the American Association of Feline Practitioners Launch Educational Web Site for Cat Owners -
11. American Humane Association Adds Direct Services in Animal-Assisted Activities and Therapy
Post Your Comments:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
Breaking Medicine Technology: